Cargando…
Functional miRNAs in breast cancer drug resistance
Owing to improved early surveillance and advanced therapy strategies, the current death rate due to breast cancer has decreased; nevertheless, drug resistance and relapse remain obstacles on the path to successful systematic treatment. Multiple mechanisms responsible for drug resistance have been el...
Autores principales: | Hu, Weizi, Tan, Chunli, He, Yunjie, Zhang, Guangqin, Xu, Yong, Tang, Jinhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865556/ https://www.ncbi.nlm.nih.gov/pubmed/29593419 http://dx.doi.org/10.2147/OTT.S152462 |
Ejemplares similares
-
Small extracellular vesicles deliver TGF‐β1 and promote adriamycin resistance in breast cancer cells
por: Tan, Chunli, et al.
Publicado: (2021) -
miR-17-3p Downregulates Mitochondrial Antioxidant Enzymes and Enhances the Radiosensitivity of Prostate Cancer Cells
por: Xu, Zhi, et al.
Publicado: (2018) -
MiRNAs and miRNA Polymorphisms Modify Drug Response
por: Li, Mu-Peng, et al.
Publicado: (2016) -
miRNAs in Lymphocytic Leukaemias—The miRror of Drug Resistance
por: Sbirkov, Yordan, et al.
Publicado: (2022) -
MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma
por: Tian, Yutong, et al.
Publicado: (2020)